tenk.fyi

RECURSION PHARMACEUTICALS, INC.

RXRXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$74.7M

26.9% YoY

Net Income

-$644.8M

39.1% YoY

EPS

$-1.44

14.8% YoY

Cash

$743.3M

25.1% YoY

FY 2025 · As of 2025-12-31